Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Canada
|
| gptkbp:focus |
research and development of generic medicines
|
| gptkbp:foundedBy |
gptkb:Barry_Sherman
|
| gptkbp:foundedYear |
1974
|
| gptkbp:headquartersLocation |
gptkb:Toronto
|
| https://www.w3.org/2000/01/rdf-schema#label |
Apotex
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:manufacturingFacilities |
gptkb:Canada
gptkb:China gptkb:Czech_Republic gptkb:India gptkb:Mexico |
| gptkbp:notableEvent |
death of founder Barry Sherman in 2017
|
| gptkbp:numberOfEmployees |
over 8,000
|
| gptkbp:operatesIn |
over 115 countries
|
| gptkbp:products |
generic drugs
|
| gptkbp:revenue |
over $1 billion (CAD)
|
| gptkbp:subsidiary |
Apobiologix
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.apotex.com/
|
| gptkbp:bfsParent |
gptkb:Barry_Sherman
|
| gptkbp:bfsLayer |
7
|